Close-up of a woman wearing glasses in an office setting

Manufacturing Expertise Recombinant Proteins

Recombinant proteins often require precise control of folding and post-translational modifications to maintain therapeutic function and stability. Avid leverages mammalian cell culture systems and disciplined process development to support consistent, scalable recombinant protein manufacturing.

Overview

Recombinant Protein Manufacturing
Built for Complexity

Key Recombinant Protein Development & Manufacturing Considerations

  • Post-translational modification control
  • Protein folding integrity
  • Formulation Development
  • Scalable purification processes
  • Expression yield and stability

How Avid Supports Recombinant Protein Programs

  • Mammalian cell line development
  • Formulation Development
  • Process characterization
  • Analytical development
  • Clinical and commercial manufacturing
  • Regulatory lifecycle support

Learn More

Recombinant Protein FAQs

Yes, when supported by validated upstream and downstream processes.

Controlling protein folding, post-translational modifications, and batch yield are central to successful production.

Connect with our team to discuss development timelines, manufacturing strategy, and
scalable CGMP production.